Ignite Creation Date:
2025-12-25 @ 4:05 AM
Ignite Modification Date:
2026-03-08 @ 5:06 AM
Study NCT ID:
NCT00042302
Status:
TERMINATED
Last Update Posted:
2012-05-23
First Post:
2002-07-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Phase III Study of Tariquidar + Paclitaxel/Carboplatin as First-Line Therapy in Non-Small Cell Lung Cancer (NSCLC)
Sponsor:
QLT Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2002-06
Start Date Type:
None
Primary Completion Date:
2003-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2003-07
Completion Date Type:
ACTUAL
First Submit Date:
2002-07-26
First Submit QC Date:
None
Study First Post Date:
2002-08-01
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2012-05-22
Last Update Post Date:
2012-05-23
Last Update Post Date Type:
ESTIMATED